Submitted 7 hours ago by scrubbed_in
Ivonescimab, a lung cancer drug developed by Akeso and Summit, showed extended survival benefits in squamous cell lung cancer patients, presented at ASCO.
A community for health content
222 subscribers
100% liked
Submitted by scrubbed_in to Health on 31 May 2026
Created by wellnoted, 3 months ago · stats
© 2026 Topicle Pty Ltd · Made in Melbourne, Australia
Topicle Beta
1 comment
Ivonescimab, a lung cancer drug developed by Akeso and Summit, showed extended survival benefits in squamous cell lung cancer patients, presented at ASCO.